A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma
Clinical trial NCT01908777 · COMPLETED
Trial details
- NCT number
- NCT01908777
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-16
- Primary completion
- 2025-10-03
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.